Literature DB >> 11708883

Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa.

F Q Liang1, T S Aleman, N S Dejneka, L Dudus, K J Fisher, A M Maguire, S G Jacobson, J Bennett.   

Abstract

The present study aimed to determine whether intravitreal administration of an adeno-associated virus (AAV) carrying ciliary neurotrophic factor (CNTF) can achieve long-term morphological and physiological rescue of photoreceptors in animal models of retinitis pigmentosa, and whether injection of this virus after degeneration begins is effective in protecting the remaining photoreceptors. We injected rAAV.CNTF.GFP intravitreally in early postnatal Prph2(Rd2/Rd2) (formerly rds/rds) mice and in adult P23H and S334ter rhodopsin transgenic rats. Contralateral eyes received an intravitreal injection of rAAV.GFP or a sham injection. We evaluated the eyes at 6 months (rats) and 8.5 to 9 months (mice) postinfection and looked for histological and electoretinographic (ERG) evidence of photoreceptor rescue and CNTF-GFP expression. Intravitreal administration of rAAV resulted in efficient transduction of retinal ganglion cells in the Prph2(Rd2/Rd2) retina, and ganglion, Muller, and horizontal/amacrine cells in the mutant rat retinas. Transgene expression localized to the retinal region closest to the injection site. We observed prominent morphological protection of photoreceptors in the eyes of all animals receiving rAAV.CNTF.GFP. We found the greatest protection in regions most distant from the CNTF-GFP-expressing cells. The Prph2(Rd2/Rd2) ERGs did not exhibit interocular differences. Eyes of the rat models administered rAAV.CNTF.GFP had lower ERG amplitudes than those receiving rAAV.GFP. The discordance of functional and structural results, especially in the rat models, points to the need for a greater understanding of the mechanism of action of CNTF before human application can be considered.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11708883     DOI: 10.1006/mthe.2001.0473

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  56 in total

1.  Ciliary neurotrophic factor: a survival and differentiation inducer in human retinal progenitors.

Authors:  Kamla Dutt; Yang Cao; Ifeoma Ezeonu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-04-29       Impact factor: 2.416

Review 2.  Gene therapy in the Retinal Degeneration Slow model of retinitis pigmentosa.

Authors:  Xue Cai; Shannon M Conley; Muna I Naash
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 3.  An overview of drug development with special emphasis on the role of visual electrophysiological testing.

Authors:  Mitchell Brigell; Cun-Jian Dong; Serge Rosolen; Radouil Tzekov
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

Review 4.  [Survival factors in the treatment of hereditary retinal degeneration].

Authors:  R Frigg; A Wenzel; C Grimm; C E Remé
Journal:  Ophthalmologe       Date:  2005-08       Impact factor: 1.059

5.  Chronic intravitreous infusion of ciliary neurotrophic factor modulates electrical retinal stimulation thresholds in the RCS rat.

Authors:  Tiffany L Kent; Inna V Glybina; Gary W Abrams; Raymond Iezzi
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

6.  Genetic supplementation of RDS alleviates a loss-of-function phenotype in C214S model of retinitis pigmentosa.

Authors:  May Nour; Steven J Fliesler; Muna I Naash
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 7.  A perspective on the role of the extracellular matrix in progressive retinal degenerative disorders.

Authors:  Muayyad R Al-Ubaidi; Muna I Naash; Shannon M Conley
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-17       Impact factor: 4.799

8.  Insights from Genetic Model Systems of Retinal Degeneration: Role of Epsins in Retinal Angiogenesis and VEGFR2 Signaling.

Authors:  Yunzhou Dong; Xue Cai; Yong Wu; Yanjun Liu; Lin Deng; Hong Chen
Journal:  J Nat Sci       Date:  2017-01

9.  Preconditioning-induced protection of photoreceptors requires activation of the signal-transducing receptor gp130 in photoreceptors.

Authors:  Yumi Ueki; Yun-Zheng Le; Srinivas Chollangi; Werner Muller; John D Ash
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-30       Impact factor: 11.205

Review 10.  Promising and delivering gene therapies for vision loss.

Authors:  Livia S Carvalho; Luk H Vandenberghe
Journal:  Vision Res       Date:  2014-08-02       Impact factor: 1.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.